| scholarly article | Q13442814 |
| meta-analysis | Q815382 |
| P50 | author | Richard M Martin | Q52574555 |
| Jonathan Sterne | Q58298018 | ||
| Andrew N. Davies | Q71559068 | ||
| P2093 | author name string | Colette M Reid | |
| Geoffrey W Hanks | |||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | meta-analysis | Q815382 |
| P1104 | number of pages | 7 | |
| P304 | page(s) | 837-843 | |
| P577 | publication date | 2006-04-01 | |
| P1433 | published in | JAMA Internal Medicine | Q177428 |
| P1476 | title | Oxycodone for cancer-related pain: meta-analysis of randomized controlled trials | |
| P478 | volume | 166 |
| Q35664979 | A randomized, double-blind, active-controlled, double-dummy, parallel-group study to determine the safety and efficacy of oxycodone/naloxone prolonged-release tablets in patients with moderate/severe, chronic cancer pain |
| Q37894992 | A systematic review of oxycodone in the management of cancer pain |
| Q38417258 | Are Physicians Safely Prescribing Opioids for Chronic Noncancer Pain? A Systematic Review of Current Evidence |
| Q24235154 | Buprenorphine for cancer pain |
| Q24240978 | Buprenorphine for cancer pain |
| Q38086150 | Cancer pain management: what's new? |
| Q39256745 | Cancer pain therapy with a fixed combination of prolonged-release oxycodone/naloxone: results from a non-interventional study |
| Q35233407 | Clinical evaluation of the efficacy of methylnaltrexone in resolving constipation induced by different opioid subtypes combined with laboratory analysis of immunomodulatory and antiangiogenic effects of methylnaltrexone |
| Q38124029 | Clinical guideline for pharmacological management of cancer pain: the Japanese Society of Palliative Medicine recommendations. |
| Q58701016 | Comparison of analgesic effect of oxycodone and morphine on patients with moderate and advanced cancer pain: a meta-analysis |
| Q28276480 | Drugs for postoperative analgesia: routine and new aspects: Part 2: opioids, ketamine and gabapentinoids |
| Q58699826 | Efficacy and Safety of High-Dose Controlled-Release Oxycodone in the Treatment of Moderate to Severe Pain in Patients with Advanced Cancer: A Retrospective Study |
| Q41869538 | Efficacy and Safety of Methadone as a Second-Line Opioid for Cancer Pain in an Outpatient Clinic: A Prospective Open-Label Study |
| Q46317999 | Efficacy and gastrointestinal tolerability of oral oxycodone/naloxone combination for chronic pain in outpatients with cancer: an observational study |
| Q34411964 | Efficacy and tolerability of oxycodone in moderate-severe cancer-related pain: A meta-analysis of randomized controlled trials |
| Q42425176 | End of contract for Drug and Therapeutics Bulletin: choices |
| Q28752585 | Endogenous opiates and behavior: 2006 |
| Q37868637 | Guidelines for supportive care in multiple myeloma 2011. |
| Q39264580 | High doses of oxycodone-naloxone combination may provide poor analgesia |
| Q60630148 | Langzeitanwendung von Opioiden bei nicht tumorbedingten Schmerzen (LONTS) |
| Q34332179 | Opioid switch from low dose of oral oxycodone to transdermal fentanyl matrix patch for patients with stable thoracic malignancy-related pain |
| Q37484027 | Opioids in people with cancer-related pain. |
| Q46547853 | Oxycodone controlled-release as first-choice therapy for moderate-to-severe cancer pain in Italian patients: results of an open-label, multicentre, observational study |
| Q24187917 | Oxycodone for cancer-related pain |
| Q38614104 | Oxycodone for cancer-related pain. |
| Q60673767 | Pharmacology of opioid analgesia: clinical principles |
| Q43058474 | Repeated administration of oxycodone modifies the gene expression of several drug metabolising enzymes in the hepatic tissue of male Sprague-Dawley rats, including glutathione S-transferase A-5 (rGSTA5) and CYP3A2. |
| Q37795441 | Role of oxycodone and oxycodone/naloxone in cancer pain management |
| Q34632120 | Switching from oxycodone to methadone in advanced cancer patients |
| Q39280226 | The use of high doses of oxycodone in an acute palliative care unit |
| Q34251507 | Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC. |
| Q36925954 | Within-subject comparison of the psychopharmacological profiles of oral oxycodone and oral morphine in non-drug-abusing volunteers |
| Q79537613 | [Diagnosis and therapy of tumor related pain] |
Search more.